Pediatric Vaccines Market, by Vaccine Type (Monovalent and Multivalent), by Vaccine Form (Attenuated Live Viruses, Inactivated Viruses, Subunits, Toxoids, Recombinant, Polysaccharides and Conjugates), by Application (Infectious Disease and Allergy), By En

Pediatric Vaccines Market, by Vaccine Type (Monovalent and Multivalent), by Vaccine Form (Attenuated Live Viruses, Inactivated Viruses, Subunits, Toxoids, Recombinant, Polysaccharides and Conjugates), by Application (Infectious Disease and Allergy), By End User (Hospitals, Pediatric Clinics, Research Organizations, and Others), and by Region - Global Forecast, 2022 - 2028

Pediatric vaccines perform significant role in reduction of various childhood infectious disease such as measles, diphtheria, Poliomyelitis, and Haemophilus influenzae type b (Hib). Increasing Government of various economies, healthcare regulatory organizations, and private organizations are focused on reducing rate of pediatric disease, which is expected to propel demand for pediatric vaccine over the forecast period. For instance, in 2013, World Health Organization (WHO): Europe launched the flu Awareness Campaign initiative to spread awareness regarding flu among the European population.adoption of pediatric vaccines have significantly led to increase in global vaccination coverage. According to the World Health Organization (WHO), immunization helps to prevent around 2 to 3 million deaths annually. Moreover, vaccination is the most cost–effective and efficient heath investment, which is accessible to hard-to-reach locations and vulnerable populations. High prevalence of infectious disease, combined with increasing numbers of government initiatives for raising awareness regarding immunization and development of novel adjuvants and therapeutic vaccines are expected to drive growth of pediatric vaccines market during the forecast period.
Restraints of the Global Pediatric Vaccines Market
Low private sector involvement in low income countries countries such as Nigeria, Cambodia, and several others is hampering growth of the market, as these countries are majorly dependent on government vaccinations.
Key features of the study:
This report provides in-depth analysis of the global pediatric vaccines market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global pediatric vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc., Sanofi, Pancea Biotec, Zydua Cadila, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech, and Indian Immunologicals Ltd.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global pediatric vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Pediatric Vaccines Market, By Vaccine Type:
Pneumonococcal Vaccine
DTP Vaccine
Rotavirus Vaccine
MMR Vaccine
Polio Vaccine
Influenza Vaccine
Hepatitis B Vaccine
Meningococcal Vaccine
Hib Vaccine
Varicella Vaccine
Global Pediatric Vaccines Market, By Technology:
Live or Attenuated Vaccine
Inactivated or Killed Vaccine
Toxoid Vaccine
Conjugate Vaccine
Subunit Vaccine
Recombinant Vaccine
Global Pediatric Vaccines Market, By Type:
Monovalent Vaccine
Multivalent Vaccine
Global Pediatric Vaccines Market, By Distribution Channel:
Government
Private
Global Pediatric Vaccines Market, By Geography:
North America
By Vaccine Type
Pneumococcal Vaccine
DTP Vaccine
Rotavirus Vaccine
MMR Vaccine
Polio Vaccine
Influenza Vaccine
Hepatitis B Vaccine
Meningococcal Vaccine
Hib Vaccine
Varicella Vaccine
By Technology:
Live or Attenuated Vaccine
Inactivated or Killed Vaccine
Toxoid Vaccine
Conjugate Vaccine
Subunit Vaccine
Recombinant Vaccine
By Type
Monovalent Vaccine
Multivalent Vaccine
By Distribution Channel
Government
Private
By Country:
U.S.
Canada
Europe
By Vaccine Type
Pneumococcal Vaccine
DTP Vaccine
Rotavirus Vaccine
MMR Vaccine
Polio Vaccine
Influenza Vaccine
Hepatitis B Vaccine
Meningococcal Vaccine
Hib Vaccine
Varicella Vaccine
By Technology:
Live or Attenuated Vaccine
Inactivated or Killed Vaccine
Toxoid Vaccine
Conjugate Vaccine
Subunit Vaccine
Recombinant Vaccine
By Type
Monovalent Vaccine
Multivalent Vaccine
By Distribution Channel
Government
Private
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Vaccine Type
Pneumococcal Vaccine
DTP Vaccine
Rotavirus Vaccine
MMR Vaccine
Polio Vaccine
Influenza Vaccine
Hepatitis B Vaccine
Meningococcal Vaccine
Hib Vaccine
Varicella Vaccine
By Technology:
Live or Attenuated Vaccine
Inactivated or Killed Vaccine
Toxoid Vaccine
Conjugate Vaccine
Subunit Vaccine
Recombinant Vaccine
By Type
Monovalent Vaccine
Multivalent Vaccine
By Distribution Channel
Government
Private
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Vaccine Type
Pneumococcal Vaccine
DTP Vaccine
Rotavirus Vaccine
MMR Vaccine
Polio Vaccine
Influenza Vaccine
Hepatitis B Vaccine
Meningococcal Vaccine
Hib Vaccine
Varicella Vaccine
By Technology:
Live or Attenuated Vaccine
Inactivated or Killed Vaccine
Toxoid Vaccine
Conjugate Vaccine
Subunit Vaccine
Recombinant Vaccine
By Type
Monovalent Vaccine
Multivalent Vaccine
By Distribution Channel
Government
Private
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Vaccine Type
Pneumococcal Vaccine
DTP Vaccine
Rotavirus Vaccine
MMR Vaccine
Polio Vaccine
Influenza Vaccine
Hepatitis B Vaccine
Meningococcal Vaccine
Hib Vaccine
Varicella Vaccine
By Technology:
Live or Attenuated Vaccine
Inactivated or Killed Vaccine
Toxoid Vaccine
Conjugate Vaccine
Subunit Vaccine
Recombinant Vaccine
By Type
Monovalent Vaccine
Multivalent Vaccine
By Distribution Channel
Government
Private
By Country:
GCC
Israel
Rest of Middle East
Africa
By Vaccine Type
Pneumococcal Vaccine
DTP Vaccine
Rotavirus Vaccine
MMR Vaccine
Polio Vaccine
Influenza Vaccine
Hepatitis B Vaccine
Meningococcal Vaccine
Hib Vaccine
Varicella Vaccine
By Technology:
Live or Attenuated Vaccine
Inactivated or Killed Vaccine
Toxoid Vaccine
Conjugate Vaccine
Subunit Vaccine
Recombinant Vaccine
By Type
Monovalent Vaccine
Multivalent Vaccine
By Distribution Channel
Government
Private
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
GlaxoSmithKline Plc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Merck & Co., Inc.
Pfizer Inc.
Sanofi S.A.
Panacea Biotec
Zydus Cadila
Emergent BioSolutions Inc.
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Indian Immunologicals Ltd.
“*” marked represents similar segmentation in other categories in the respective section.